Keyphrases
Drug Utilization Study
76%
Direct Oral Anticoagulants
63%
Anticoagulant Use
47%
Insulin
40%
Rivaroxaban
39%
Apixaban
39%
Pharmacoepidemiology
39%
Incidence Rate
39%
Bipolar Disorder
38%
Human Insulin
38%
Population-based Cohort Study
36%
Monotherapy
31%
Treatment Failure
31%
Ischemic Stroke
31%
Exchangeability
31%
Carvedilol
31%
Cancer Risk
31%
European Countries
31%
Validation Data
31%
Lithium
31%
Non-vitamin K Antagonist Oral Anticoagulants
31%
CAR T-cell Therapy
31%
Nordic Countries
31%
Unmeasured Confounding
31%
Benzodiazepines
31%
Survival Outcomes
31%
Combination Therapy
31%
Patients with Heart Failure
31%
Stockholm
31%
Stroke Prevention in Atrial Fibrillation
31%
Non-valvular Atrial Fibrillation
31%
Warfarin
31%
Mania
31%
Dichotomous Outcomes
31%
Diabetes
31%
Time-varying Exposure
31%
Maintenance Treatment
31%
Serum Cholesterol
31%
Lipid-lowering Drugs
31%
Rate Ratio
31%
Women with Diabetes
31%
Chronic Obstructive Pulmonary Disease
31%
User Characteristics
31%
Benzodiazepine Drugs
31%
Z-drugs
31%
Breast Cancer Subtypes
31%
Beta-blockers
31%
History of Myocardial Infarction
31%
Register Study
31%
High Risk
30%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
100%
Drug Utilization
95%
Anticoagulant Agent
55%
Combination Therapy
40%
Rivaroxaban
39%
Apixaban
39%
Bipolar Disorder
38%
Human Insulin
38%
Recombinant Human Insulin
38%
Pharmacoepidemiology
36%
Chronic Obstructive Lung Disease
31%
Monotherapy
31%
Direct Oral Anticoagulant
31%
Beta Adrenergic Receptor Blocking Agent
31%
Warfarin
31%
Carvedilol
31%
Atrial Fibrillation
31%
Heart Infarction
31%
Congestive Heart Failure
31%
Z-Drug
31%
Antilipemic Agent
31%
Chimeric Antigen Receptor
31%
Randomized Controlled Trial
31%
Comorbidity
28%
Malignant Neoplasm
25%
Adverse Event
23%
Benzodiazepine
22%
Prescription Drug
21%
Insulin Detemir
19%
Sodium Valproate
19%
Insulin Glargine
19%
Dabigatran
15%
Ischemic Heart Disease
15%
Observational Study
15%
Safety Case
15%
Medicine and Dentistry
Primary Health Care
39%
Cohort Analysis
38%
Elderly Patient
35%
Gene Linkage
31%
Treatment Effect
31%
Atrial Fibrillation
31%
T Cell
31%
Chimeric Antigen Receptor
31%
Cancer Risk
31%
Apoplexy
31%
Diabetes
31%
Bipolar Disorder
31%
Recombinant Human Insulin
31%
Benzodiazepine
31%
Medicine
31%
Benzodiazepine Derivative
31%
Antithrombotic
31%
Human Insulin
31%
Breast Cancer
31%
Randomized Controlled Trial
31%
Prescription Drug
21%
Drug Exposure
21%
Insulin Glargine
19%
Insulin Detemir
19%
Cancer
16%
Brain Ischemia
15%
Health Care
15%
Bleeding
15%
